Phaarmasia Ltd Experiences Increased Buying Activity Amid Sector Gains and Volatility
2025-04-03 14:30:18Phaarmasia Ltd, a microcap player in the Pharmaceuticals & Drugs sector, is witnessing significant buying activity today. The stock has shown a notable performance over the past month, with a gain of 14.67%, outperforming the Sensex, which increased by 4.41% during the same period. However, in the short term, Phaarmasia has faced challenges, with a 1.97% decline over the past week compared to the Sensex's drop of 1.67%. Despite recent volatility, Phaarmasia's price summary indicates a gap up at the open, reflecting positive market sentiment. The stock's intraday high has not been specified, but it is essential to note that it has underperformed its sector by 2.2% today. The stock has also shown erratic trading patterns, not trading on three days out of the last 20. In terms of moving averages, Phaarmasia is currently above its 20-day moving average but below the 5-day, 50-day, 100-day, and 200-day moving ...
Read MorePhaarmasia Ltd Faces Intense Selling Pressure Amid Significant Price Declines
2025-03-28 12:30:15Phaarmasia Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a 1.97% decline in its stock price today, compared to a modest 0.30% drop in the Sensex. Over the past week, Phaarmasia has lost 4.37%, while the Sensex has gained 0.61%. In the longer term, Phaarmasia's performance has been notably poor, with a staggering 43.29% decline over the past three months, contrasting sharply with the Sensex's slight decrease of 1.68%. Year-to-date, the stock is down 39.57%, while the Sensex has only dipped by 0.98%. Despite a positive performance of 8.96% over the past month, the overall trend indicates a challenging environment for Phaarmasia, particularly when compared to the Sensex's 5.71% gain in the same period. The stock's erratic trading behavior, having not traded on one day out of the last 20, may also...
Read MorePhaarmasia Ltd Faces Intense Selling Pressure Amid Consecutive Losses and Market Struggles
2025-03-26 13:35:07Phaarmasia Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend has resulted in consecutive days of losses, highlighting a challenging market environment for the microcap pharmaceutical company. Over the past week, Phaarmasia has declined by 3.68%, contrasting sharply with the Sensex, which has gained 2.73% during the same period. In the broader context, Phaarmasia's performance over the last month shows a modest increase of 1.01%, yet it still lags behind the Sensex's 3.89% rise. The three-month performance is particularly concerning, with Phaarmasia down 44.67%, while the Sensex has only dipped by 1.23%. Year-to-date, the stock has dropped 37.94%, compared to the Sensex's slight decline of 0.81%. The price summary indicates that Phaarmasia has outperformed its sector by 0.8% today. However, its moving averages reveal a mixed picture, being higher th...
Read MorePhaarmasia Ltd Experiences Strong Buying Activity Amidst Recent Price Fluctuations
2025-03-25 10:35:15Phaarmasia Ltd is currently witnessing strong buying activity, with a notable increase of 1.99% in its stock price today, significantly outperforming the Sensex, which rose by 0.56%. This uptick marks a positive shift in sentiment, especially considering the stock's recent performance trends. Over the past week, Phaarmasia has seen a decline of 1.91%, contrasting with the Sensex's gain of 4.14%. However, its one-month performance shows a modest increase of 4.90%, slightly lagging behind the Sensex's 5.12% rise. Despite a challenging three-month period, where Phaarmasia's stock plummeted by 45.40%, the current buying pressure may be attributed to a variety of factors, including potential market corrections or sector-specific developments within the pharmaceuticals and drugs industry. The stock opened with a gap up today, indicating strong initial buyer interest, and reached an intraday high that reflects th...
Read MorePhaarmasia Ltd Faces Intense Selling Pressure Amid Continued Price Declines
2025-03-24 14:35:07Phaarmasia Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. This trend marks a continuation of consecutive days of losses for the microcap pharmaceutical company. Over the past week, Phaarmasia has declined by 3.83%, while the Sensex has gained 5.21%, highlighting a stark contrast in performance. In the last month, Phaarmasia's stock has decreased by 2.26%, compared to a 4.80% increase in the Sensex. The three-month performance reveals a more alarming decline of 46.46% for Phaarmasia, while the Sensex has only dipped by 0.56%. Year-to-date, Phaarmasia is down 36.80%, in contrast to the Sensex's marginal decline of 0.14%. The price summary indicates that Phaarmasia has underperformed its sector by 0.69% today. While the stock is currently above its 20-day moving average, it remains below the 5-day, 50-day, 100-day, and 200-day moving av...
Read MorePhaarmasia Ltd Faces Intense Selling Pressure Amid Consecutive Losses and Market Underperformance
2025-03-21 11:35:07Phaarmasia Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has experienced consecutive losses over the past three days, resulting in a total decline of 3.83%. Today, Phaarmasia's performance dipped by 1.89%, contrasting sharply with the Sensex, which gained 0.73%. Over the past week, Phaarmasia has lost 1.92%, while the Sensex has risen by 4.17%. The stock's performance over the last month reveals a decline of 7.15%, compared to a modest 2.12% increase in the Sensex. More notably, Phaarmasia's three-month performance shows a staggering drop of 44.34%, while the Sensex has only decreased by 1.45%. In terms of moving averages, Phaarmasia is currently above its 20-day moving average but below the 5-day, 50-day, 100-day, and 200-day moving averages. This trend indicates a challenging market position for the microcap pharmaceutic...
Read MorePhaarmasia Ltd Faces Intensified Selling Pressure Amid Ongoing Price Declines
2025-03-20 10:35:45Phaarmasia Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, raising concerns among market observers. Over the past month, Phaarmasia has declined by 10.05%, while the Sensex has managed a modest gain of 0.23%. The three-month performance reveals a stark contrast, with Phaarmasia down 43.25% compared to the Sensex's decline of just 2.73%. Year-to-date, Phaarmasia has lost 35.57%, significantly underperforming the Sensex, which has decreased by only 2.85%. Even over longer periods, such as three years, Phaarmasia's growth of 4.69% pales in comparison to the Sensex's impressive 31.19% increase. Today's performance indicates that Phaarmasia is underperforming its sector by 0.45%. While the stock is currently above its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-da...
Read MorePhaarmasia Ltd Faces Intense Selling Pressure Amid Ongoing Price Declines
2025-03-18 10:35:15Phaarmasia Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, raising concerns among market observers. Over the past week, Phaarmasia has declined by 6.59%, significantly underperforming the Sensex, which has only seen a 1.29% increase. In the last month, Phaarmasia's performance has been even more troubling, with a drop of 17.18%, while the Sensex has decreased by just 1.20%. The three-month performance reveals a stark decline of 38.56% for Phaarmasia compared to the Sensex's 6.39% drop. Year-to-date, the stock has plummeted by 34.29%, contrasting sharply with the Sensex's decline of 3.94%. Despite a positive annual performance of 11.01% against the Sensex's 3.17%, the longer-term view shows Phaarmasia lagging behind, particularly over three years and five years. The stock is currently underperf...
Read MorePhaarmasia Ltd Faces Intense Selling Pressure Amid Consecutive Losses and Declining Performance
2025-03-13 14:35:05Phaarmasia Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend has resulted in consecutive days of losses, raising concerns among market observers. Over the past week, Phaarmasia has experienced a notable decline of 19.27%, contrasting sharply with the Sensex, which has only dipped by 0.64% during the same period. In the longer term, Phaarmasia's performance has been underwhelming, with a 1-month decline of 26.11% compared to the Sensex's 2.99% drop. The stock has also seen a 3-month decrease of 31.71%, while the Sensex fell by 10.07%. Year-to-date, Phaarmasia is down 35.57%, significantly underperforming the Sensex's decline of 5.47%. Despite a 4.13% increase over the past year, Phaarmasia's overall trajectory remains concerning, particularly when viewed against the backdrop of the broader market. The stock's price summary indicates that it is curr...
Read MoreClosure of Trading Window
29-Mar-2025 | Source : BSEThe Company closed its trading window for previous Quarter on December 27 2024 the trading window remained closed from January 01 2025 till 48 hours after the declaration of results of Unaudited Financial Statements for the Quarter ended December 31 2024.
Closure of Trading Window
29-Mar-2025 | Source : BSEIntimation of Closure of Trading Window for the Quarter ending Financial Year 31st March 2025.
Informational Mail: Correction Of Clerical Error In Board Meeting Outcome Dated 14.02.2025.
24-Feb-2025 | Source : BSEIn continuation of the Board Meeting outcome submitted on 14.02.2025. We would like to bring to your attention a clerical error in the Board Outcome. The Board decided To authorize Mr. Vinay Sapte to identify suitable buyers and determine a fair price for the sale of land of Unit I Plot No. 16 Phase III IDA Jeedimetla Hyderabad during their meeting. However mistakenly Due to clerical error the same was written as To authorize Mr. Vinay Sapte to identify suitable buyers and determine fair price for sale of Unit I in the Jeedimetla area Hyderabad. Therefore the Board Meeting outcome is corrected and informed to all the stakeholders. We are sorry for this clerical error. This is for your information.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available